Analysis of the efficacy of intensity‑modulated radiotherapy and two‑dimensional conventional radiotherapy in nasopharyngeal carcinoma with involvement of the cervical spine

Jiang,Hao; Wang,Gengming; Song,Hongwei; Xu,Hongbo; Zhang,Yajun; Zhou,Yufu; Cai,Hanfei; Duan,Shimiao

doi:10.3892/ol.2015.3668

Analysis of the efficacy of intensity‑modulated radiotherapy and two‑dimensional conventional radiotherapy in nasopharyngeal carcinoma with involvement of the cervical spine

Authors:
- Hao Jiang
- Gengming Wang
- Hongwei Song
- Hongbo Xu
- Yajun Zhang
- Yufu Zhou
- Hanfei Cai
- Shimiao Duan
View Affiliations

Affiliations: Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China, Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, P.R. China
Published online on: September 3, 2015 https://doi.org/10.3892/ol.2015.3668
Pages: 2731-2738

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to retrospectively analyze the clinical efficacy and side‑effects of two‑dimensional conventional radiotherapy (2D‑CRT) and intensity‑modulated radiotherapy (IMRT) in 53 NPC patients with cervical spine involvement, without distant metastases. In total, 53 patients were enrolled in the present study, with 24 being treated with IMRT and 29 being treated with 2D‑CRT. All 53 patients received platinum‑based concurrent chemotherapy and 4‑6 cycles of adjuvant chemotherapy subsequent to radiation. The patients were clinically staged according to the seventh edition of the UICC and AJCC staging systems. Overall survival (OS), local progression‑free survival (LPFS) and distant metastasis‑free survival (DMFS) rates were calculated. The 3‑ and 5‑year OS rates were 87.7% and 45.5% in the IMRT‑treated group and 65.5% and 9.1% in the 2D‑CRT‑treated group (P=0.01). The 3‑ and 5‑year LPES rates were 87.4% and 69.9% in the IMRT‑treated group compared with 49.4% and 9.4% in the 2D‑CRT‑treated group, respectively (P=0.00). The 3‑ and 5‑year DMFS rates were 94.4 and 40.8% in the IMRT‑treated group and 79.8 and 30.4% in the 2D‑CRT‑treated group (P=0.13). N stage (P=0.00) and radiotherapy methods (P=0.01) were relevant to the OS and LPFS rates, it also revealed a significant difference when the DMFS rates were analyzed in N stage. The incidence of dry mouth in the IMRT group was significantly lower (P=0.01), but there was no statistically significant difference in acute oropharyngeal mucositis or myelosuppression. IMRT had significant advantages in local control and OS compared with conventional 2D‑CRT, but IMRT failed to reduce the incidence of distant metastasis.

View Figures

View References

1	Liu Q, Chen JO, Huang QH and Li YH: Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: A population-based study. Chin J Cancer. 32:325–333. 2013. View Article : Google Scholar : PubMed/NCBI
2	Sun Y, Tang LL, Chen L, Li WF, Mao YP, Liu LZ, Lin AH, Li L and Ma J: Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system. BMC Cancer. 12:682012. View Article : Google Scholar : PubMed/NCBI
3	Peng G, Wang T, Yang KY, Zhang S, Zhang T, Li Q, Han J and Wu G: A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 104:286–293. 2012. View Article : Google Scholar : PubMed/NCBI
4	Lee CC, Chu ST, Chou P, Lee CC and Chen LF: The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma. Clin Otolaryngol. 33:442–449. 2008. View Article : Google Scholar : PubMed/NCBI
5	Razek A Abdel Khalek Abdel and King A: MRI and CT of nasopharyngeal carcinoma. AJR Am J Roentgenol. 198:11–18. 2012. View Article : Google Scholar : PubMed/NCBI
6	Poon PY, Tsang VH and Munk PL: Tumour extent and T stage of nasopharyngeal carcinoma: A comparison of magnetic resonance imaging and computed tomographic findings. Can Assoc Radiol J. 51:287–295. 2000.PubMed/NCBI
7	Zhang SX, Han PH, Zhang GQ, Wang RH, Ge YB, Ren ZG, Li JS and Fu WH: Comparison of SPECT/CT, MRI and CT in diagnosis of skull base bone invasion innasopharyngeal carcinoma. Biomed Mater Eng. 24:1117–1124. 2014.PubMed/NCBI
8	Edge S, Fritz AG, Byrd DR, Greene FL and Compton CC: Pharynx (including base of tongue, soft palate and uvula). AJCC Cancer Staging Manual. Edge S, Bryd DR, Compton CC, Fritz AG, Greene FL and Trotti A: (7th). Springer. (New York, NY). 41–56. 2010.
9	World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 310:2191–2194. 2013. View Article : Google Scholar : PubMed/NCBI
10	Purdy JA: Current ICRU definitions of volumes: Limitations and future directions. Semin Radiat Oncol. 14:27–40. 2004. View Article : Google Scholar : PubMed/NCBI
11	Zong JF, Lin SJ, Zhang Z, Chen YB, Quo QJ and Pan JJ: Comparative study of nasopharyngeal carcinoma staging system between the Chinese 2008 and 1992 Fuzhou. Chin J Radiat Oncol. 19:481–485. 2010.
12	Chen L, Liu LZ, Chen M, Li WF, Yin WJ, Lin AH, Sun Y, Li L and Ma J: Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment. Int J Radiat Oncol Biol Phys. 84:196–202. 2012. View Article : Google Scholar : PubMed/NCBI
13	Cao CN, Luo JW, Gao L, Yi JL, Huang XD, Wang K, Zhang SP, Qu Y, Li SY, Cai WM, et al: Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma. Oral Oncol. 49:175–181. 2013. View Article : Google Scholar : PubMed/NCBI
14	Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC and Wang AY: Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol. 33:501–508. 2003. View Article : Google Scholar : PubMed/NCBI
15	Chen CY, Han F, Zhao C, Lu LX, Sun Y, Liu XF and Lu TX: Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone. Br J Radiol. 82:452–458. 2009. View Article : Google Scholar : PubMed/NCBI
16	Feng AC, Wu MC, Tsai SY, Chan KY, Cheng SH, Wang A, Chen SS, Jian JJ, Terng SD and Huang AT: Prevertebral muscle involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 65:1026–1035. 2006. View Article : Google Scholar : PubMed/NCBI
17	Zhou GQ, Mao YP, Chen L, Li WF, Liu LZ, Sun Y, Chen Y, Tian L, Lin AH, Li L, et al: Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 82:1090–1097. 2012. View Article : Google Scholar : PubMed/NCBI
18	Leung SW and Lee TF: Treatment of nasopharyngeal carcinoma by tomotherapy: Five-year experience. Radiat Oncol. 8:1072013. View Article : Google Scholar : PubMed/NCBI
19	Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ and Ma J: How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 80:661–668. 2011. View Article : Google Scholar : PubMed/NCBI
20	Han F, Zhao C, Huang SM, Lu LX, Huang Y, Deng XW, Mai WY, Teh BS, Butler EB and Lu TX: Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol). 24:569–576. 2012. View Article : Google Scholar : PubMed/NCBI
21	Siala W, Mnejja W, Khabir A, Ben Mahfoudh K, Boudawara T, Ghorbel A, Frikha M and Daoud J: Late neurotoxicity after nasopharyngeal carcinoma treatment. Cancer Radiother. 13:709–714. 2009. View Article : Google Scholar : PubMed/NCBI
22	Lee AW, Law SC, Ng SH, Chan DK, Poon YF, Foo W, Tung SY, Cheung FK and Ho JH: Retrospective analysis of nasopharyngeal carcinoma treated during 1976–1985: Late complications following megavoltage irradiation. Br J Radiol. 65:918–928. 1992. View Article : Google Scholar : PubMed/NCBI
23	Teo PM, Leung SF, Chan AT, Leung TW, Choi PH, Kwan WH, Lee WY, Chau RM, Yu PK and Johnson PJ: Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys. 48:1311–1322. 2000. View Article : Google Scholar : PubMed/NCBI
24	Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, Lu TX and Zhao C: Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer. 48:3422–3428. 2012. View Article : Google Scholar : PubMed/NCBI